Resources

Alzheimer’s Disease Treatments and Expectations

Home | Resources

Research Objectives:

  • Understand the current treatment landscape for Alzheimer’s Disease patients
  • Explore what physicians know about and expect for products in development for Alzheimer’s Disease

Methodology:
Method: 9-minute MicroSurvey via InCrowd
Crowds: US Neurologists
Sample Size: n=100
Fielding Period: March 10-13, 2019
Screening Criteria:
Qualified respondents are US-based neurologists who:

  • Treat at least 10 Alzheimer’s Disease patients in a typical month
  • Are at least somewhat knowledgeable about products in development for the treatment of Alzheimer’s Disease

One key finding:

  • Responding neurologists tend to treat over 30 Alzheimer’s patients a month across all severity levels (39% mild, 38% moderate, 23% severe).

Download the full report now!

Please fill out the form below to access this content

Related Resources

IV Fluid Supply Chain Disruptions 

IV Fluid Supply Chain Disruptions 

Discover the Impact of Hurricane Helene on IV Fluid Availability When Hurricane Helene disrupted a key IV fluid manufacturing facility in the southeastern US, healthcare systems felt the ripple effects. InCrowd conducted research to uncover how this shortage has...

read more
Physician Burnout: Knowing Your Audience 

Physician Burnout: Knowing Your Audience 

Physician Engagement in a Time of Accelerated Professional Burnout  As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...

read more
ASH 2023 Post-Event Round-Up 

ASH 2023 Post-Event Round-Up 

Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023  In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and...

read more